CLOSE ×

    General Meeting

    The General Meeting is the corporate body that has the highest authority in Biotage. All shareholders may participate at the General Meetings. 

    The Annual General Meeting (the “AGM”) attends to such matters as the development of the Company’s business during the preceding fiscal year and resolutions are passed in a number of important items such as approving the Annual Report, disposition of the result of the year, dividends, discharge of the Board of Directors and the CEO, election of members of the Board of Directors and the auditors, fees and allocation of fees to the Board of Directors and the auditors, and guidelines for compensation of the executive management. 

    The notice for the AGM is published at the earliest six weeks prior to and no later than four weeks before the AGM. 

    A shareholder has the right to request that a certain item is made subject to the AGM. To ensure that the Company is able to amend such an item to the notice for the AGM, such request shall be with the Company no later than seven weeks prior to the AGM. The request to have an item addressed at the AGM shall be made to the Company’s Board of Directors at the address set out below: 

    Biotage AB 
    Attn. CLO
    P.O. Box 8
    SE-751 03 Uppsala 
    Sweden 

    The General Meeting does also resolve in such important matters as changes and amendments to the Articles of Association, share based incentive programs, issue of shares and derivatives of shares, authorization of the Board of Directors to resolve on the issue of shares and derivatives of shares, approval of issues of shares and derivatives shares that are resolved by the Board of Directors but conditioned to the approval of the General Meeting. 

    The Company may hold other General Meetings than the AGM. The notice for an extra ordinary General Meeting, were the subject is not the change of the Company’s Articles of Association, shall be published at the earliest six weeks prior to and not no later than two weeks before the General Meeting. If the subject of the General Meeting concerns a change of the Company’s Articles of Association, then the notice period for the AGM applies.

    In order to mitigate the spread of Covid-19, the Board of Directors has decided that the Annual General Meeting will be conducted by advance voting only, without physical presence of shareholders, proxies and third parties. Biotage welcomes all shareholders to exercise their voting rights at this Annual General Meeting through advance voting on the basis of temporary statutory rules, according to the procedure set out below. Information on the resolutions passed at the Annual General Meeting will be published on 28 April 2021, as soon as the result of the voting has been finally confirmed.

    In the advance voting form, the shareholders may request that a resolution on one or several of the matters on the proposed agenda below should be deferred to a so-called continued general meeting, which cannot be conducted solely by way of advance voting. Such continued general meeting shall take place if the Annual General Meeting so resolves or if shareholders with at least one tenth of all shares in the company so request.